The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 20, 2010

Filed:

Sep. 04, 2002
Applicants:

Yingfu LI, Nara-ken, JP;

Akihiko Watanabe, Shizuoka-ken, JP;

Timothy B. Lowinger, Guilford, CT (US);

Kevin Bacon, Hyogo-ken, JP;

Norihiro Kawamura, Nara-ken, JP;

Takuya Shintani, Kyoto-fu, JP;

Tetsuo Kikuchi, Nara-ken, JP;

Toshiya Moriwaki, Nara-ken, JP;

Klaus Urbahns, Hyogo-ken, JP;

Keiko Fukushima, Saitama-ken, JP;

Noriko Nunami, Nara-ken, JP;

Takashi Yoshino, Shiga-ken, JP;

Toshiki Murata, Nara-ken, JP;

Megumi Yamauchi, Shiga-ken, JP;

Hiroko Yoshino, Shiga-ken, JP;

Inventors:

Yingfu Li, Nara-ken, JP;

Akihiko Watanabe, Shizuoka-ken, JP;

Timothy B. Lowinger, Guilford, CT (US);

Kevin Bacon, Hyogo-ken, JP;

Norihiro Kawamura, Nara-ken, JP;

Takuya Shintani, Kyoto-fu, JP;

Tetsuo Kikuchi, Nara-ken, JP;

Toshiya Moriwaki, Nara-ken, JP;

Klaus Urbahns, Hyogo-ken, JP;

Keiko Fukushima, Saitama-ken, JP;

Noriko Nunami, Nara-ken, JP;

Takashi Yoshino, Shiga-ken, JP;

Toshiki Murata, Nara-ken, JP;

Megumi Yamauchi, Shiga-ken, JP;

Hiroko Yoshino, Shiga-ken, JP;

Assignee:

Axikin Pharmaceuticals, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/55 (2006.01); A01N 43/62 (2006.01); A61K 31/497 (2006.01); C07D 243/08 (2006.01); C07D 241/04 (2006.01); C07D 295/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC type chemokine receptor) antagonistic activity, and can be used for the prophylaxis and treatment of diseases associated with CCR3 activity, in particular for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders.


Find Patent Forward Citations

Loading…